Clinical Study
Prevalence, Comorbid Associations and Prognostic Value of the Hyperdense Middle Cerebral Artery Sign
Table 2
Clinical features recorded and analysed for all ischemic stroke and TIA patients.
| Demographic/
clinical factor | HMCAS +ve
(%) | HMCAS −ve
(%) | † |
| | Sex (male) | 11 (73) | 53 (52) | 0.507 | | History of TIA | 1 (7) | 26 (25) | 0.307 | | History of stroke | 1 (7) | 25 (25) | 0.305 | | History of AF | 8 (53) | 19 (19) | 0.042 | | History of CCF | 0 | 10 (10) | 0.606 | | History of IHD | 2 (7) | 19 (19) | 1.000 | | Hypercholesterolemia | 11 (73) | 80 (78) | 1.000 | | Hypertension | 9 (60) | 76 (75) | 0.667 | |
Smoking | 3 (20) | 24 (24) | 1.000 | | Diabetes | 2 (20) | 16 (16) | 1.000 | | High hematocrit | 0 | 4 (4) | 1.000 | | High hemoglobin | 0 | 5 (5) | 1.000 | Subtherapeutic INR
(patients with AF) | 6 (75) | 14 (73) | 1.000 | | Significant carotid stenosis | 4 (27) | 9 (9) | 0.099 |
|
|
Fisher’s exact test (two-tailed) value compares the proportion with risk factor to the presence of an HMCAS.
|
